Ryman Healthcare Achieves First Positive Free Cash Flow in Decade, Boosting Investor Confidence
Ryman Healthcare turns a decade‑long slump into a NZ$56 m positive free‑cash‑flow, driven by higher pricing, unit sales growth and a balance‑sheet reset, signaling a sustainable turnaround.
3 minutes to read